IL6 and COVID-19: While previous studies demonstrated elevated levels of HBA and HBB in the airway mucus of severe COVID-19 patients as well as in the serum of patients with high IL-6 compared to healthy subjects [36,56], we also detected high plasma levels of HBA and HBB in patients with comorbidities compared to their disease controls.